Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
Background: Schizophrenia is associated with a lowered life expectancy due to cardiovascular disease. This is, at least in part, related to an increased vulnerability to the development of metabolic syndrome (MetS) in patients with schizophrenia. The dysregulation of apolipoproteins (Apos) may also...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2019-07-01
|
| Ráidu: | Heliyon |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2405844019356932 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|